You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas: Inflammatory Diseases
30 March 2023 - Germany-based pharmaceutical company Boehringer Ingelheim reported on Wednesday a strong performance in 2022.The company stated that 2022 was a year in which 30 million patients benefi...
27 March 2023 - - US-based cell therapy and regenerative medicine company Athersys, Inc. (NASDAQ: ATHX) has announced planned amendments to its MASTERS-2 clinical trial protocol following a Type B mee...
27 March 2023 - - Canada-based biopharmaceutical company FSD Pharma Inc's (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Australian entity, FSD Pharma Australia Pty Ltd. received the certificate of appro...
24 March 2023 - - US-based late-stage precision immunology biopharmaceutical company NImmune Biopharma has launched following the acquisition of omilancor, NIM-1324, and the entire LANCL portfoli...
22 March 2023 - - Japan-based fine chemicals company DIC Corp has started joint business development in the area of polyphenols with California-based biotech startup Debut, a vertically integrate...
22 March 2023 - - Bioelectronic medicine researchers at The Feinstein Institutes for Medical Research have developed a new method for studying neural signals transmitted to the brain through...
Related Headlines
Sanofi granted EU approval of Dupixent for young children with severe atopic dermatitis
TFS HealthScience expands into Israel
Advanced Infusion Care now offers Kedrion Biopharma infusion therapy GAMMAKED
Enthera Pharmaceuticals Initiates Phase 1 Clinical Trial with Lead Candidate Ent001
Sanofi reports Dupixent application for CSU treatment accepted for FDA review